What's new

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised

Jun 18, 2025 - 12:25
 0
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

A startup banks $65M to pursue ‘inclusive precision medicine’

Next Article

Human medicines European public assessment report (EPAR): Phelinun, melphalan, D...

Related Posts

PSUSA/00001842/202410

PSUSA/00001842/202410

Jun 6, 2025  0

Eighth European Medicines Agency (EMA) and EFPIA bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2025, 15:00 (CEST) to 8 July 2025, 17:00 (CEST)

Eighth European Medicines Agency (EMA) and EFPIA bilate...

Jun 12, 2025  0

Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Date of authorisation: 07/09/1999, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0